Own Brand Update: Administrative delays in the Australian Therapeutic Goods Administration (TGA) granting a Good Manufacturing Practice (GMP) certificate to the U.S. manufacturer of VESIsorb® has affected the launch timeline for the Avani Rapid CBD capsules. Although the TGA has not provided specific timing guidance, ECS anticipates the launch to occur in Q3 FY24, with production commencing post-certification. ECS’ RAP veterans’ brand is steadily growing, delivering 86% increase compared to the prior quarter.
ECS Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
